上海复星医药（集团）股份有限公司 关于参与认购之投资基金完成私募投资基金备案的公告

Overview - The company Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has participated in the establishment of a private equity investment fund named "China Resources (Chengdu) Pharmaceutical Industry Equity Investment Fund Partnership (Limited Partnership)" [2] Group 1 - On October 28, 2025, the company signed a partnership agreement with 11 other investors to jointly establish the fund [2] - The fund has completed its registration with the Asset Management Association of China [3] - The fund is managed by Shenzhen China Resources Capital Equity Investment Co., Ltd. and is custodied by China Merchants Bank Co., Ltd. [3]